José Carlos Bouso is a Clinical Psychologist and PhD in Pharmacology. He developed his scientific activity at the Universidad Autónoma de Madrid, at the Instituto de Investigación Biomédica IIB-Sant Pau in Barcelona and at the Instituto Hospital del Mar de Investigaciones Médicas de Barcelona (IMIM). During this time, he developed studies on the therapeutic effects of MDMA (“ecstacy”) and psychopharmacological studies on the acute and long-term neuropsychiatric effects of many substances, both synthetic and plant-derived. As Scientific Director of ICEERS, José Carlos coordinates studies on the potential benefits of psychoactive plants, mainly cannabis, ayahuasca and ibogaine, with the aim of improving public health. He is co-author of numerous scientific articles and several book chapters. He is also a member of the MARC (Medical Anthropology Research Center) at the Universitat Rovira i Virgili in Tarragona, visiting professor in the mental health program at the Faculty of Medicine of the University of São Paulo in Riberão Preto, Brazil, and vice-president of the Society of Clinical Endocannabinology (SEC).
Óscar Soto Angona is a psychiatrist, researcher and therapist. Graduated in Medicine from the University of Valladolid, he specialized in Psychiatry at the Vall d’Hebron University Hospital, where he has also developed research and clinical activity in the Resistant Depression Program. Doctoral candidate at the Universitat Autónoma de Barcelona, his interest is focused on the phenomenology of altered states of consciousness induced by psychedelics, and their therapeutic utility. He has been or is a sub-investigator or therapist in several clinical trials with psychedelics, including esketamine, psilocybin, MDMA, and 5MeoDMT. He is president and founder of the Spanish Society of Psychedelic Medicine.